Evidence for L‐dopa incorporation into cell proteins in patients treated with levodopa
KJ Rodgers, PM Hume, JGL Morris… - Journal of …, 2006 - Wiley Online Library
Levodopa (L‐dopa) is the most widely used agent for the symptomatic relief of Parkinson's
disease. There is concern that chronic L‐dopa treatment may be detrimental, with some …
disease. There is concern that chronic L‐dopa treatment may be detrimental, with some …
Evidence for L‐dopa incorporation into cell proteins in patients treated with levodopa
K Rodgers, P Hume, J Morris… - Journal of …, 2006 - researchprofiles.canberra.edu.au
Levodopa (L-dopa) is the most widely used agent for the symptomatic relief of Parkinson's
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa.
KJ Rodgers, PM Hume, JG Morris… - Journal of …, 2006 - europepmc.org
Levodopa (L-dopa) is the most widely used agent for the symptomatic relief of Parkinson's
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa.
KJ Rodgers, PM Hume, JGL Morris… - Journal of …, 2006 - search.ebscohost.com
Levodopa (L-dopa) is the most widely used agent for the symptomatic relief of Parkinson's
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
[引用][C] Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa
KJ RODGERS, PM HUME… - Journal of …, 2006 - pascal-francis.inist.fr
Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa
KJ Rodgers, PM Hume, JGL Morris… - Journal of …, 2006 - pubmed.ncbi.nlm.nih.gov
Levodopa (L-dopa) is the most widely used agent for the symptomatic relief of Parkinson's
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa
KJ Rodgers, PM Hume, JGL Morris… - Journal of …, 2006 - opus.lib.uts.edu.au
Levodopa (L-dopa) is the most widely used agent for the symptomatic relief of Parkinson's
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa
KJ Rodgers, PM Hume… - Journal of …, 2006 - researchdirect.westernsydney.edu …
Levodopa (L-dopa) is the most widely used agent for the symptomatic relief of Parkinson's
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …
disease. There is concern that chronic L-dopa treatment may be detrimental, with some …